An Open Label Pharmacokinetic Study of Naftin for Tinea Corporis
NCT02466867
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
27
Enrollment
INDUSTRY
Sponsor class
Conditions
Tinea Corporis
Interventions
DRUG:
Naftin® Cream, 2% (younger pediatric cohort)
DRUG:
Naftin® Cream, 2% (older pediatric cohort)
Sponsor
Merz North America, Inc.